Double-J stent-related lower urinary tract symptoms: a prospective randomized trial of mirabegron, solifenacin, tamsulosin, and tadalafil and their combinations
Abstract
BACKGROUND: Clinical use of ureteral stents may lead to associated symptoms comparable to overactive bladder and lower urinary tract symptoms (LUTS). This study examined the effectiveness of mirabegron, solifenacin, tamsulosin, and tadalafil and their combinations in patients with LUTS linked to double-J stents, divided into seven treatment groups.METHODS: Consecutive random sampling was used to identify 161 people with LUTS for this double-blind randomized clinical research. Mirabegron 50 mg (group A), solifenacin 5 mg (group B), tamsulosin 0.4 mg (group C), tadalafil 10 mg (group D), mirabegron 25 mg+solifenacin 5 mg (group E), tamsulosin 0.4 mg+solifenacin 5 mg (group F), and placebo (group G) were given to patients in a 1:1 ratio. The Ureteral Stent Symptoms Questionnaire was used to compare treatment outcomes across six indices on days 7, 14, 21, and 28 post ureteral stent insertion (pain and urinary symptoms, general health conditions, sexual matters, working performance, and other problems). The data were analyzed using ANOVA, and significance was determined using a P value cutoff of 0.05.RESULTS: The combination of tamsulosin and solifenacin worked better to treat difficulties with working performance, sexual matters, and additional problems. Tadalafil performed better than other drugs for pain symptoms and general health conditions.CONCLUSIONS: LUTS complaints were reduced in all seven therapy groups. However, the combination of tamsulosin and solifenacin and…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 161 participants or records.
Read the paper
Related studies
- Ureteral Stent‐Related Symptoms and Pharmacotherapy: A Brief Narrative Review
- Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study
- The efficacy of adjunctive alpha-blockers on ureteroscopy procedure for ureteral stones: a systematic review and meta-analysis
- A randomized controlled trial study on effectiveness between tadalafil versus combination mirabegron and solifenacin on treatment of ureteral stent-related symptoms
- Pharmacological treatment of bladder stent symptoms
- Comparative efficacy of solifenacin and tamsulosin in alleviating stent-related symptoms: A systematic review and meta-analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.